Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chemaissani

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 20, 1991
[Pleural fibrosis as a side effect of years-long methysergide therapy]R Müller, P Weller, A Chemaissani
Pneumologie (Stuttgart, Germany)|April 1, 1997
[Pleurodesis in malignant pleural effusion: bleomycin vs. mitoxantrone]M Schmidt, G Schaarschmidt, A Chemaissani
European Journal of Gastroenterology & Hepatology|November 1, 1995
Oesophageal ulceration by tuberculosis: a rare cause of dysphagiaB Krakamp, P Leidig, A Chemaissani, et al.
Der Anaesthesist|February 28, 2009
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis]D Knüttgen, M Kamp, M Ströhlein, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study GroupA A Fauser, B Duclos, A Chemaissani, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2001
Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trialE Laack, T Mende, J Benk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trialR Rosell, U Gatzemeier, D C Betticher, et al.
Seminars in Oncology|June 1, 1997
A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancerC Manegold, P Drings, J von Pawel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancerC Manegold, B Bergman, A Chemaissani, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 1999
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancerW W ten Bokkel Huinink, B Bergman, A Chemaissani, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|September 20, 1991
[Pleural fibrosis as a side effect of years-long methysergide therapy]R Müller, P Weller, A Chemaissani
Pneumologie (Stuttgart, Germany)|April 1, 1997
[Pleurodesis in malignant pleural effusion: bleomycin vs. mitoxantrone]M Schmidt, G Schaarschmidt, A Chemaissani
European Journal of Gastroenterology & Hepatology|November 1, 1995
Oesophageal ulceration by tuberculosis: a rare cause of dysphagiaB Krakamp, P Leidig, A Chemaissani, et al.
Der Anaesthesist|February 28, 2009
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis]D Knüttgen, M Kamp, M Ströhlein, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study GroupA A Fauser, B Duclos, A Chemaissani, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2001
Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trialE Laack, T Mende, J Benk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trialR Rosell, U Gatzemeier, D C Betticher, et al.
Seminars in Oncology|June 1, 1997
A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancerC Manegold, P Drings, J von Pawel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancerC Manegold, B Bergman, A Chemaissani, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 1999
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancerW W ten Bokkel Huinink, B Bergman, A Chemaissani, et al.
Pageof 2